| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K16147474 |
| PharmacoGx | BRD-K16147474 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CLASP2 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.07 |
| mRNA | TPRG1L | CTRPv2 | pan-cancer | AAC | 0.077 | 0.07 |
| mRNA | GTF3C6 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | TMEM160 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | TUBGCP6 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.07 |
| mRNA | HN1 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | CLDN2 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.07 |
| mRNA | RGS1 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | ZNF675 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | C12orf29 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
